🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,410.00
-75.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST

NeoImmuneTech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22,846-31,796-40,883-53,405-60,406-52,482
Depreciation & Amortization
2,8582,4983,6733,2102,8021,873
Loss (Gain) From Sale of Assets
-35.25-213.95321.851.8912.78108.48
Asset Writedown & Restructuring Costs
0.2340.1488.92---
Stock-Based Compensation
-48.53-426.711,4125,8935,6319,204
Provision & Write-off of Bad Debts
75.06118.84936.2225.98--
Other Operating Activities
3,4035,923-2,018-2,1382,909-271.91
Change in Accounts Receivable
-1,381-12.38-18.9---
Change in Other Net Operating Assets
1,971-1,183-2,975-3,5486,6467,682
Operating Cash Flow
-17,225-25,053-39,062-49,761-42,405-33,887
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-91.78-79.64-1,549-791.39-2,477-2,710
Sale of Property, Plant & Equipment
90.3230.491.26-6.98-
Sale (Purchase) of Intangibles
-14,563-7,111----
Investment in Securities
-2,026-9,445-12,403---
Other Investing Activities
1,6001,2782,3812,715836.55-1,119
Investing Cash Flow
-14,992-15,002-11,5712,087-3,150-3,828

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--12,403---
Long-Term Debt Repaid
--792.78-1,186-1,178-1,036-713.73
Net Debt Issued (Repaid)
-750.94-792.7811,217-1,178-1,036-713.73
Issuance of Common Stock
3,06448,688-41.26402.56115,763
Other Financing Activities
-1,036-1,036-0--0
Financing Cash Flow
1,26246,86011,217-1,136-633.32115,049

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1,120-1,373-1,592-97.54-3,075-682.37
Miscellaneous Cash Flow Adjustments
---0-0-0-
Net Cash Flow
-32,0755,431-41,008-48,908-49,26376,652

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-17,316-25,133-40,612-50,552-44,881-36,596
Free Cash Flow Growth
------
Free Cash Flow Margin
-262.28%-26504.37%-23835.33%---
Free Cash Flow Per Share
-135.73-213.57-411.85-511.40-454.42-384.18
Levered Free Cash Flow
-27,151-20,882-24,302-38,500-28,855-25,579
Unlevered Free Cash Flow
-25,560-19,366-23,849-38,360-28,692-25,442

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
169.06213.82221.25220.99253.77226.7
Cash Income Tax Paid
--20.6104.86133.6258.232.91
Change in Working Capital
-632.26-1,196-2,994-3,5486,6467,682